Search

Astellas Pharma Inc.
  • Top MenuAbout
    Corporate Information
    Europe is a global centre of excellence in healthcare and Astellas is committed to supporting Europe, the Middle East and Africa (EMEA)…
    Read More
    • Philosophy
      • Group Code of Conduct
    • Vision & Strategy
    • Corporate Information
    • Policy & Position Statements
    • Ethics & Compliance
    • Astellas Transparency
    • Medical Education
      • Support for Medical Education
  • Top MenuTherapy areas
    • ADVAGRAF™
    • BETMIGA ™
    • EVRENZO™
    • MYCAMINE™
    • PADCEV™
    • PROGRAFT™
    • VESICARE™
    • VESOMNI™
    • XOSPATA™
    • XTANDI™
  • Top MenuProducts
  • Top MenuInnovation
    Clinical Trials
    Astellas has established a website to disclose information obtained from Astellas-sponsored clinical trials…
    Read More
    • R & D
      • Clinical Trials
      • Approach
      • Ethics & Principles
    • Investigator Sponsored Research
  • Top MenuSustainability
  • Top MenuNews
    Media Contacts
    The Astellas EMEA Corporate Communications team will respond to calls and emails from journalists…
    Read More
    • News
    • Media Contacts
    • Social Media Code of Conduct

Common header menu

  • CAREERS
  • CONTACT US
  • WORLDWIDE
  • NETHERLANDS
  • WORLDWIDE - NETHERLANDS
  1. Home
  2. Leaving Astellas Pharma NL

You are now leaving www.astellas.com/nl

You are about to leave the www.astellas.com/nl environment and be redirected to:

Continue

Cancel

LogoSolgan

Follow us on social media

linkedin_icon twitter_icon

Bottom footer menu

  • SITE MAP
  • PRIVACY STATEMENT
  • TERMS OF USE
  • CONTACT US
  • COOKIE BELEID
© 2021-2023 Astellas Pharma B.V.

Cookievoorkeuren bijwerken